Impact of Enhanced Compliance Initiatives on the Efficacy of Rosuvastatin in Reducing Low Density Lipoprotein Cholesterol Levels in Patients With Primary Hypercholesterolaemia. Swiss Med Wkly 2008, 138 (2930), 420-426. https://doi.org/10.4414/smw.2008.12120.